In ovarian cancer, MEOX1 activates the SPHK1/S1P pathway to promote both tumor progression and tumor–stroma crosstalk. MEOX1‐dependent signaling drives CAF activation, enhances VEGF‐C expression, and stimulates lymphangiogenesis, ultimately facilitating lymph node metastasis.
Jiajia Li +10 more
wiley +1 more source
Association of Fibroblast Growth Factor 23 and Cardiac Mechanics in the Cardiovascular Health Study. [PDF]
Jain K +8 more
europepmc +1 more source
Suppression of Fibroblast Growth Factor 23 in UMR106 Osteoblast-Like Cells and MC3T3-E1 Cells by Adipokine Chemerin. [PDF]
Vogt J, Daferner K, Föller M.
europepmc +1 more source
The Severity of Carotid Calcifications, but Not Fibroblast Growth Factor 23, Is Associated with Mortality in Hemodialysis: A Single Center Experience. [PDF]
Moldovan D.
europepmc +1 more source
Burosumab treatment for fibroblast growth factor-23-associated hypophosphatemia in an adult patient with severe fibrous dysplasia in McCune-Albright syndrome: case report and review of the literature. [PDF]
Stelmachowska-Banaś M +4 more
europepmc +1 more source
Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism. [PDF]
Courbon G, David V.
europepmc +1 more source
Correspondence: Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease. [PDF]
Palupi-Baroto R +5 more
europepmc +1 more source

